21 results match your criteria: "University of South Florida and H. Lee Moffitt Cancer Center[Affiliation]"
iScience
April 2023
Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Advances in the understanding of the tumor microenvironment have led to development of immunotherapeutic strategies, such as chimeric antigen receptor T cells (CAR-Ts). However, despite success in blood malignancies, CAR-T therapies in solid tumors have been hampered by their restricted infiltration. Here, we used our understanding of early cytotoxic lymphocyte infiltration of human lymphocytes in solid tumors to investigate the receptors in normal, adjacent, and tumor tissues of primary non-small-cell lung cancer specimens.
View Article and Find Full Text PDFHum Pathol
June 2023
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
JAK2 rearrangement (JAK2-R) in acute lymphoblastic leukemia (ALL) is rare and often categorized as B-ALL with BCR::ABL1-like features based on the World Health Organization classification. We report 10 patients with JAK2-R ALL, 9 males and 1 female, with a median age 40.5 years.
View Article and Find Full Text PDFInt J Mol Sci
February 2023
Precision BioSciences, Inc., Durham, NC 27701, USA.
Myelodysplastic Syndromes (MDSs) are bone marrow (BM) failure malignancies characterized by constitutive innate immune activation, including NLRP3 inflammasome driven pyroptotic cell death. We recently reported that the danger-associated molecular pattern (DAMP) oxidized mitochondrial DNA (ox-mtDNA) is diagnostically increased in MDS plasma although the functional consequences remain poorly defined. We hypothesized that ox-mtDNA is released into the cytosol, upon NLRP3 inflammasome pyroptotic lysis, where it propagates and further enhances the inflammatory cell death feed-forward loop onto healthy tissues.
View Article and Find Full Text PDFDermatol Ther (Heidelb)
January 2022
Stanford University, Stanford, CA, USA.
The CCR4-directed monoclonal antibody mogamulizumab has been shown to significantly improve progression-free survival and overall response rate compared with vorinostat in adults with relapsed/refractory mycosis fungoides (MF) and Sézary syndrome (SS). One of the most common adverse events seen with mogamulizumab in MF/SS patients is rash. Because of the protean nature of MF/SS and the variable clinical and histopathological features of mogamulizumab-associated rash, healthcare providers may have difficulty distinguishing rash from disease, and may not be aware of appropriate treatment strategies for this generally manageable adverse event.
View Article and Find Full Text PDFMyelodysplastic syndromes (MDS) are heterogeneous hematopoietic stem cell malignancies that can phenotypically resemble other hematologic disorders. Thus, tools that may add to current diagnostic practices could aid in disease discrimination. Constitutive innate immune activation is a pathogenetic driver of ineffective hematopoiesis in MDS through Nod-like receptor protein 3 (NLRP3)-inflammasome-induced pyroptotic cell death.
View Article and Find Full Text PDFBlood Adv
July 2020
Department of Malignant Hematology.
The in-clinic phosphatidylinositol 3-kinase (PI3K) inhibitors idelalisib (CAL-101) and duvelisib (IPI-145) have demonstrated high rates of response and progression-free survival in clinical trials of B-cell malignancies, such as chronic lymphocytic leukemia (CLL). However, a high incidence of adverse events has led to frequent discontinuations, limiting the clinical development of these inhibitors. By contrast, the dual PI3Kδ/casein kinase-1-ε (CK1ε) inhibitor umbralisib (TGR-1202) also shows high rates of response in clinical trials but has an improved safety profile with fewer severe adverse events.
View Article and Find Full Text PDFLeukemia
August 2019
Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Myelodysplastic syndromes (MDS) are characterized by dysplastic and ineffective hematopoiesis that can result from aberrant expansion and activation of myeloid-derived suppressor cells (MDSCs) within the bone marrow (BM) niche. MDSCs produce S100A9, which mediates premature death of hematopoietic stem and progenitor cells (HSPCs). The PD-1/PD-L1 immune checkpoint impairs immune responses by inducing T-cell exhaustion and apoptosis, but its role in MDS is uncharacterized.
View Article and Find Full Text PDFBlood Adv
September 2017
Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
Approved therapies that target the B-cell receptor (BCR) signaling pathway, such as ibrutinib and idelalisib, are known to show activity in chronic lymphocytic leukemia (CLL) via their direct effects on crucial survival pathways in malignant B cells. However, these therapies also have effects on T cells in CLL by mediating toxicity and possibly controlling disease. By focusing on the effects of BCR signaling inhibitors on the T-cell compartment, we may gain new insights into the comprehensive biological outcomes of systemic treatment to further understand mechanisms of drug efficacy, predict the toxicity or adverse events, and identify novel combinatorial therapies.
View Article and Find Full Text PDFCurr Treat Options Cardiovasc Med
April 2017
Cardio-Oncology Program, Division of Cardiovascular Medicine, University of South Florida and H. Lee Moffitt Cancer Center & Research Institute, 2 Tampa General Circle, Tampa, FL, 33606, USA.
The development of tyrosine kinase inhibitors (TKIs) dramatically changed the treatment landscape for many different cancers including chronic myeloid leukemia (CML). With the introduction of imatinib, the first TKI developed and approved to effectively treat CML, patient survival has increased dramatically and, in some cases, this fatal cancer can be managed as a chronic disease. Since the approval of imatinib in 2002, four additional TKIs have been developed to treat this disease including the second-generation TKIs nilotinib, dasatinib, and bosutinib and the third-generation TKI ponatinib.
View Article and Find Full Text PDFCurr Treat Options Cardiovasc Med
May 2016
Division of Cardiovascular Medicine, University of South Florida and H. Lee Moffitt Cancer Center & Research Institute, 2 Tampa General Circle, Tampa, FL, 33606, USA.
Abnormal intracellular signaling has been implicated in the development of many different types of cancer. Therapies targeting these abnormal pathways have revolutionized the treatment of many malignancies leading to significantly improved outcomes and survival. Despite these advances, cardiovascular toxicity is a frequently reported complication.
View Article and Find Full Text PDFInt J Cell Biol
December 2015
Division of Hematopathology and Laboratory Medicine, Department of Oncologic Sciences, University of South Florida and H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Cell staining is a necessary and useful technique for visualizing cell morphology and structure under a microscope. This technique has been used in many areas such as cytology, hematology, oncology, histology, virology, serology, microbiology, cell biology, and immunochemistry. One of the key pieces of equipment for preparing a slide for cell staining is cytology centrifuge (cytocentrifuge) such as cytospin.
View Article and Find Full Text PDFPLoS One
June 2016
Department of Microbiology & Immunology, Medical University of South Carolina, Charleston, South Carolina, United States of America; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.
Bruton's Tyrosine Kinase (BTK) and IL-2 Inducible T-cell Kinase (ITK) are enzymes responsible for the phosphorylation and activation of downstream effectors in the B-cell receptor (BCR) signaling and T cell receptor (TCR) signaling pathways, respectively. Ibrutinib is an FDA-approved potent inhibitor of both BTK and ITK that impairs B-cell and T-cell function. CD4 T cells and B cells are essential for the induction of chronic graft-versus-host disease (cGVHD).
View Article and Find Full Text PDFDrug Alcohol Depend
February 2015
Tobacco Research and Intervention Program, University of South Florida and H. Lee Moffitt Cancer Center and Research Institute, 4115 E. Fowler Ave., Tampa, FL 33617, USA. Electronic address:
Background: Despite tremendous growth in research examining the role of cognitive bias in addictive behaviors, scant consideration has been paid to the close association between smoking and drinking behavior. This study sought to determine whether an association between smoking and drinking could be observed at an implicit level using a novel cognitive bias task, as well as characterize the relationship between performance on this task and clinically relevant variables (i.e.
View Article and Find Full Text PDFJ Pain Symptom Manage
January 2007
University of South Florida and H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA.
The current study evaluated a newly developed self-report measure of cognitive complaints with cancer patients, the Functional Assessment of Cancer Therapy Cognitive Scale (FACT-Cog). Six or 12 months following hematopoietic stem cell transplantation, participants completed a psychosocial assessment that included the FACT-Cog and a neuropsychological assessment. Using a criterion of two or more times a week, an average of 12 of a total of 50 items were endorsed as complaints on the FACT-Cog.
View Article and Find Full Text PDFOncologist
March 2006
Department of Interdisciplinary Oncology, University of South Florida and H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Clonal disorders of large granular lymphocytes (LGLs) represent a spectrum of biologically distinct lymphoproliferative diseases originating either from mature T cells (CD3+) or natural killer (NK) cells (CD3-). Both subtypes, T-cell and NK-cell LGL leukemia, can manifest as indolent or aggressive disorders. The majority of patients with T-cell LGL leukemia have a clinically indolent course with a median survival time >10 years.
View Article and Find Full Text PDFJ Urol
April 2003
Department of Interdisciplinary Oncology, University of South Florida and H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA.
Purpose: We evaluated the technique of intraoperative gamma probe directed rib biopsy in patients with suspected metastatic prostate adenocarcinoma. This technique can be used to identify accurately the rib in question, reliably obtain sufficient tissue for diagnosis, be performed with minimal patient morbidity and potentially alter the course of therapy.
Materials And Methods: From 1996 to 2001, 8 patients with biopsy proved adenocarcinoma of the prostate and suspicious rib lesions on radionuclide bone scanning underwent open rib biopsy as part of the evaluation for metastatic disease.
Cancer Control
July 2002
Department of Neurosurgery, University of South Florida and H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Background: Dissection of mucosa from the nasal septum during a transsphenoidal approach may lead to significant morbidity. Endoscopic techniques that obviate this dissection and its complications have been successful for pituitary operations. These techniques, however, are generally not stereoscopic, can add significant costs, and in many instances require additional surgical personnel.
View Article and Find Full Text PDFJ Oncol Manag
May 2002
Dept. of Interdisciplinary Oncology, University of South Florida and H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA.
Cancer therapy is associated with inherent adverse effects and the need for complete, consistent and accurate reporting of toxicity is paramount in multicenter cooperative oncology clinical trials. Accurate toxicity information is essential to weigh the costs and benefits associated with new treatment regimens. A major issue faced by investigators and clinical trial coordinators today is the lack of clear directions regarding what method should be used in toxicity assessment in cooperative oncology clinical trials.
View Article and Find Full Text PDFJ Abnorm Psychol
February 2002
Department of Psychology, University of South Florida and H. Lee Moffitt Cancer Center and Research Institute, Tampa 33617, USA.
The balanced placebo design (BPD) was used to evaluate the independent effects of nicotine dose and smoking-related expectancies on self-reported anxiety, urge to smoke, and withdrawal symptoms. After anxious mood was induced, participants smoked either a de-nicotinized cigarette or one with standard nicotine content. Nicotine dose was crossed with instructions that the cigarette was either de-nicotinized or standard.
View Article and Find Full Text PDFCell Growth Differ
April 2000
Department of Internal Medicine, University of South Florida and H. Lee Moffitt Cancer Center and Research Institute, Tampa 33612, USA.
The role of the mitogen-activated protein kinase (MAPK) signal transduction pathway in the proliferation of mammalian cells has been well established. However, there are relatively few reports concerning cell differentiation being mediated by MAPK. The effect of phorbol 12-myristate 13-acetate (PMA) on cell differentiation and signal transduction in a human myeloid leukemia cell line, TF-1a, was investigated.
View Article and Find Full Text PDFJ Urol
May 1997
Department of Surgery, University of South Florida and H. Lee Moffitt Cancer Center, Tampa, USA.
Purpose: We discuss the incidence and diagnosis of parastomal hernias in association with continent urinary reservoirs. We also present a surgical technique appropriate for correction of this complication.
Materials And Methods: We evaluated 21 patients with parastomal hernia after construction of a continent urinary reservoir.